SEC Form 4 · accession 0001131096-15-000017
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Eric Robinson
Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2015 | M | 25,000 | $25.67 | A | 28,692 | D | |
| Common StockF1,F2 | Feb 5, 2015 | S | 1,250 | $140.49 | D | 27,442 | D | |
| Common StockF1,F3 | Feb 5, 2015 | S | 5,950 | $141.62 | D | 21,492 | D | |
| Common StockF1,F4 | Feb 5, 2015 | S | 5,860 | $142.61 | D | 15,632 | D | |
| Common StockF1,F5 | Feb 5, 2015 | S | 2,403 | $143.51 | D | 13,229 | D | |
| Common StockF1,F6 | Feb 5, 2015 | S | 9,537 | $144.75 | D | 3,692 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $25.67 | Feb 5, 2015 | M | 25,000 | D | May 24, 2009 | Mar 2, 2019 | Common Stock | 25,000 | 20,000 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on October 21, 2014, in accordance with Rule 10b5-1.
- F2This price represents the weighted average of sales ranging from $139.82 to $140.80. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average of sales ranging from $141.13 to $142.11. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average of sales ranging from $142.25 to $143.23. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average of sales ranging from $143.27 to $143.85. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F6This price represents the weighted average of sales ranging from $144.50 to $145.11. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.